Linda C. Hogan, Head, Business Development and Strategy at CoLucid Pharmaceuticals, Inc. (CLCD), sold 2,581 shares at $37.74 ($96K) on 2016-10-03, disclosed to the SEC on 2016-10-05.
Open-market sale of $96k CLCD by Head, Business Development and Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.74 | 719 | $27K | 28.2% |
| 2 | $36.41 | 185 | $7K | 7.0% |
| 3 | $37.08 | 1,677 | $62K | 64.7% |
| Total | $37.22 avg | 2,581 | $96K | 100% |
| Filing → |
| CLCD | SELL | 2016-11-07 | $53K | — | Filing → |
| CLCD | SELL | 2016-11-01 | $22K | — | Filing → |
| CLCD | SELL | 2016-09-07 | $969K | — | Filing → |